181 related articles for article (PubMed ID: 23852186)
21. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
22. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.
Glick ID; Pham D; Davis JM
J Clin Psychiatry; 2006 Aug; 67(8):1261-5. PubMed ID: 16965205
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
24. Psychotropic Polypharmacy Among Youths With Serious Emotional and Behavioral Disorders Receiving Coordinated Care Services.
Wu B; Bruns EJ; Tai MH; Lee BR; Raghavan R; dosReis S
Psychiatr Serv; 2018 Jun; 69(6):716-722. PubMed ID: 29540121
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
27. Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.
Hilt RJ; Chaudhari M; Bell JF; Wolf C; Koprowicz K; King BH
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):83-9. PubMed ID: 24506790
[TBL] [Abstract][Full Text] [Related]
28. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
[TBL] [Abstract][Full Text] [Related]
29. Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients.
Araz Altay M; Bozatlı L; Demirci Şipka B; Görker I
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108992
[No Abstract] [Full Text] [Related]
30. Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey.
Bilsky S; Blumenthal H; Ramadan B; Lewis S; Leen-Feldner EW
J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):416-425. PubMed ID: 36074100
[No Abstract] [Full Text] [Related]
31. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
[TBL] [Abstract][Full Text] [Related]
32. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
33. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.
Potter MP; Liu HY; Monuteaux MC; Henderson CS; Wozniak J; Wilens TE; Biederman J
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):529-38. PubMed ID: 19877977
[TBL] [Abstract][Full Text] [Related]
34. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME
J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
[TBL] [Abstract][Full Text] [Related]
35. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
36. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
Schubart JR; Camacho F; Leslie D
Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
[TBL] [Abstract][Full Text] [Related]
38. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
Hirano Y; Ii Y
Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
[TBL] [Abstract][Full Text] [Related]
39. Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: A prospective cohort study of 2712 inpatients.
Golden JC; Goethe JW; Woolley SB
J Affect Disord; 2017 Oct; 221():6-10. PubMed ID: 28628769
[TBL] [Abstract][Full Text] [Related]
40. Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study.
McIntyre RS; Jerrell JM
J Clin Psychiatry; 2009 Feb; 70(2):240-6. PubMed ID: 19192465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
